MARKET

TRML

Tourmaline Bio
TRML
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-16.6124
-
4.756
1,235,773,887.58
Cantor Fitzgerald Suspends Overweight Rating on Tourmaline Bio
Benzinga · 10/29 13:54
Tourmaline Bio (TRML): Evaluating Valuation After Recent Strong Share Price Gains
Simply Wall St · 10/29 02:19
Tourmaline Bio Inc. Files Initial Beneficial Ownership Statement Naming Novartis AG
Reuters · 10/28 16:13
Tourmaline Bio to Delist from Nasdaq and Deregister
TipRanks · 10/28 14:58
Tourmaline Bio Inc. Completes Merger and Terminates $100 Million ATM Sales Agreement
Reuters · 10/28 14:43
Tourmaline Bio acquisition completed by Novartis
TipRanks · 10/28 14:10
NOVARTIS AG - WITH COMPLETION OF ACQUISITION, SHARES OF COMMON STOCK, PAR VALUE $0.0001 PER SHARE ( "SHARES")
Reuters · 10/28 13:52
Novartis Q3 profit swells as oncology drugs drive growth
Seeking Alpha · 10/28 08:13
More

Webull offers Tourmaline Bio stock information, including NASDAQ: TRML real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TRML stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TRML stock methods without spending real money on the virtual paper trading platform.